BEAM logo

Beam Therapeutics (BEAM) Cash from financing

annual CFF:

$7.74M-$268.71M(-97.20%)
December 31, 2024

Summary

  • As of today (July 4, 2025), BEAM annual cash flow from financing activities is $7.74 million, with the most recent change of -$268.71 million (-97.20%) on December 31, 2024.
  • During the last 3 years, BEAM annual CFF has fallen by -$748.40 million (-98.98%).
  • BEAM annual CFF is now -98.98% below its all-time high of $756.14 million, reached on December 31, 2021.

Performance

BEAM Cash from financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBEAMcash flow metrics

quarterly CFF:

$473.38M+$469.94M(+13645.03%)
March 31, 2025

Summary

  • As of today (July 4, 2025), BEAM quarterly cash flow from financing activities is $473.38 million, with the most recent change of +$469.94 million (+13645.03%) on March 31, 2025.
  • Over the past year, BEAM quarterly CFF has increased by +$470.48 million (+16240.32%).
  • BEAM quarterly CFF is now at all-time high.

Performance

BEAM quarterly CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBEAMcash flow metrics

TTM CFF:

$478.22M+$470.48M(+6081.72%)
March 31, 2025

Summary

  • As of today (July 4, 2025), BEAM TTM cash flow from financing activities is $478.22 million, with the most recent change of +$470.48 million (+6081.72%) on March 31, 2025.
  • Over the past year, BEAM TTM CFF has increased by +$297.29 million (+164.31%).
  • BEAM TTM CFF is now -44.69% below its all-time high of $864.59 million, reached on September 30, 2021.

Performance

BEAM TTM CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBEAMcash flow metrics

Cash from financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

BEAM Cash from financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-97.2%+10000.0%+164.3%
3 y3 years-99.0%+750.2%-14.4%
5 y5 years-81.3%+145.3%+144.5%

BEAM Cash from financing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-99.0%at lowat high>+9999.0%at high+6081.7%
5 y5-year-99.0%at lowat high>+9999.0%-44.7%+6081.7%
alltimeall time-99.0%at lowat high>+9999.0%-44.7%+6081.7%

BEAM Cash from financing History

DateAnnualQuarterlyTTM
Mar 2025
-
$473.38M(>+9900.0%)
$478.22M(+6081.7%)
Dec 2024
$7.74M(-97.2%)
$3.44M(+172.9%)
$7.74M(-79.6%)
Sep 2024
-
$1.26M(+848.9%)
$38.01M(-48.3%)
Jun 2024
-
$133.00K(-95.4%)
$73.52M(-59.4%)
Mar 2024
-
$2.90M(-91.4%)
$180.93M(-34.6%)
Dec 2023
$276.45M(+147.7%)
$33.71M(-8.3%)
$276.45M(+0.6%)
Sep 2023
-
$36.78M(-65.8%)
$274.75M(+14.7%)
Jun 2023
-
$107.54M(+9.3%)
$239.53M(+55.2%)
Mar 2023
-
$98.42M(+207.4%)
$154.33M(+38.3%)
Dec 2022
$111.59M(-85.2%)
$32.01M(+1949.4%)
$111.59M(+10.4%)
Sep 2022
-
$1.56M(-93.0%)
$101.12M(-75.9%)
Jun 2022
-
$22.34M(-59.9%)
$420.44M(-24.7%)
Mar 2022
-
$55.68M(+158.4%)
$558.54M(-26.1%)
DateAnnualQuarterlyTTM
Dec 2021
$756.14M(+134.6%)
$21.54M(-93.3%)
$756.14M(-12.5%)
Sep 2021
-
$320.89M(+100.0%)
$864.59M(+59.0%)
Jun 2021
-
$160.44M(-36.7%)
$543.80M(+42.1%)
Mar 2021
-
$253.27M(+94.8%)
$382.58M(+18.7%)
Dec 2020
$322.32M(+680.8%)
$129.99M(>+9900.0%)
$322.32M(+67.0%)
Sep 2020
-
$94.00K(-112.1%)
$193.03M(-1.3%)
Jun 2020
-
-$779.00K(-100.4%)
$195.63M(-0.4%)
Mar 2020
-
$193.01M(>+9900.0%)
$196.38M(+375.8%)
Dec 2019
$41.28M(-77.0%)
$699.00K(-74.0%)
$41.28M(+1.7%)
Sep 2019
-
$2.69M(<-9900.0%)
$40.58M(+7.1%)
Jun 2019
-
-$20.00K(-100.1%)
$37.89M(-0.1%)
Mar 2019
-
$37.91M
$37.91M
Dec 2018
$179.73M
-
-

FAQ

  • What is Beam Therapeutics annual cash flow from financing activities?
  • What is the all time high annual CFF for Beam Therapeutics?
  • What is Beam Therapeutics annual CFF year-on-year change?
  • What is Beam Therapeutics quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for Beam Therapeutics?
  • What is Beam Therapeutics quarterly CFF year-on-year change?
  • What is Beam Therapeutics TTM cash flow from financing activities?
  • What is the all time high TTM CFF for Beam Therapeutics?
  • What is Beam Therapeutics TTM CFF year-on-year change?

What is Beam Therapeutics annual cash flow from financing activities?

The current annual CFF of BEAM is $7.74M

What is the all time high annual CFF for Beam Therapeutics?

Beam Therapeutics all-time high annual cash flow from financing activities is $756.14M

What is Beam Therapeutics annual CFF year-on-year change?

Over the past year, BEAM annual cash flow from financing activities has changed by -$268.71M (-97.20%)

What is Beam Therapeutics quarterly cash flow from financing activities?

The current quarterly CFF of BEAM is $473.38M

What is the all time high quarterly CFF for Beam Therapeutics?

Beam Therapeutics all-time high quarterly cash flow from financing activities is $473.38M

What is Beam Therapeutics quarterly CFF year-on-year change?

Over the past year, BEAM quarterly cash flow from financing activities has changed by +$470.48M (+16240.32%)

What is Beam Therapeutics TTM cash flow from financing activities?

The current TTM CFF of BEAM is $478.22M

What is the all time high TTM CFF for Beam Therapeutics?

Beam Therapeutics all-time high TTM cash flow from financing activities is $864.59M

What is Beam Therapeutics TTM CFF year-on-year change?

Over the past year, BEAM TTM cash flow from financing activities has changed by +$297.29M (+164.31%)
On this page